Skip to main content

View full-text article in PMC

. 2018 Oct 24;62(11):e01022-18. doi: 10.1128/AAC.01022-18

TABLE 1.

In vitro antifungal susceptibility of 189 clinical and environmental isolates of A. flavus to azoles

Drug	Source	Susceptibility^a
Drug	Source	Range	MIC₅₀	MIC₉₀	GM	ECV	% ≤ECV
Itraconazole	Clinical	0.03–16.0	0.12	0.5	0.14	1	98.3
	Environmental	0.03–0.125	0.06	0.125	0.06		100
Voriconazole	Clinical	0.03–8.0	0.5	1.0	0.43	1	95.04
	Environmental	0.15–1.0	0.5	1.0	0.50		100
Posaconazole	Clinical	0.015–0.5	0.06	0.25	0.05	0.25	98.95
	Environmental	0.015–0.06	0.03	0.03	0.022		100

^a

All values are in μg/ml. GM, geometric mean; ECV, epidemiological cut off value (34).